ePT--the Electronic Newsletter of Pharmaceutical Technology, Oct 4, 2012 - Pharmaceutical Technology

Latest Issue
PharmTech

Latest Issue
PharmTech Europe

ePT--the Electronic Newsletter of Pharmaceutical Technology, Oct 4, 2012
News
US Science Advisors Issue Report on Innovation in Drug Discovery and Development
By Amy Ritter
The President's Council of Advisors on Science and Technology (PCAST) released a report containing recommendations for boosting innovation in drug discovery and development.
Merck Serono Launches New Spin-off Company; Provides Update on Restructuring
By Patricia Van Arnum
Merck Serono's Asceneuron is the third company to be spun off from the company's Entrepreneur Partnership Program that was launched to mitigate the impact from recent restructuring at its Geneva site.
EMA Aims to Facilitate Biosimilars Development
By Stephanie Sutton
The European Medicines Agency has updated its guidance on biosimilar medicines, with the aim of helping companies to avoid unnecessary repetition of clinical trials.
Week of October 1, 2012: Merck Returns Brinavess Rights to Cardiome; Sigma-Aldrich Expands in Scotland; and More
Merck Returns Brinavess Rights to Cardiome; Sigma-Aldrich Expands in Scotland; and More.
Regulatory Roundup: Week of October 1, 2012
FDA launches BeSafeRx program and releases guidance for industry.

ADVERTISEMENT

LCGC E-mail Newsletters

Subscribe: Click to learn more about the newsletter
| Weekly
| Monthly
|Monthly
| Weekly

Survey
FDASIA was signed into law two years ago. Where has the most progress been made in implementation?
Reducing drug shortages
Breakthrough designations
Protecting the supply chain
Expedited reviews of drug submissions
More stakeholder involvement
Reducing drug shortages
70%
Breakthrough designations
4%
Protecting the supply chain
17%
Expedited reviews of drug submissions
2%
More stakeholder involvement
7%
View Results
Eric Langerr Outsourcing Outlook Eric LangerTargeting Different Off-Shore Destinations
Cynthia Challener, PhD Ingredients Insider Cynthia ChallenerAsymmetric Synthesis Continues to Advance
Jill Wechsler Regulatory Watch Jill Wechsler Data Integrity Key to GMP Compliance
Sean Milmo European Regulatory WatchSean MilmoExtending the Scope of Pharmacovigilance Comes at a Price
Click here